These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

268 related articles for article (PubMed ID: 18203283)

  • 1. Hypermethylated SFRP2 gene in fecal DNA is a high potential biomarker for colorectal cancer noninvasive screening.
    Wang DR; Tang D
    World J Gastroenterol; 2008 Jan; 14(4):524-31. PubMed ID: 18203283
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Detection of promoter hypermethylation of Wnt antagonist genes in fecal samples for diagnosis of early colorectal cancer.
    Zhang H; Zhu YQ; Wu YQ; Zhang P; Qi J
    World J Gastroenterol; 2014 May; 20(20):6329-35. PubMed ID: 24876755
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Combined detection of plasma GATA5 and SFRP2 methylation is a valid noninvasive biomarker for colorectal cancer and adenomas.
    Zhang X; Song YF; Lu HN; Wang DP; Zhang XS; Huang SL; Sun BL; Huang ZG
    World J Gastroenterol; 2015 Mar; 21(9):2629-37. PubMed ID: 25759530
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Detection of aberrant methylation in fecal DNA as a molecular screening tool for colorectal cancer and precancerous lesions.
    Huang ZH; Li LH; Yang F; Wang JF
    World J Gastroenterol; 2007 Feb; 13(6):950-4. PubMed ID: 17352030
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Variation risks of SFRP2 hypermethylation between precancerous disease and colorectal cancer.
    Sui C; Wang G; Chen Q; Ma J
    Tumour Biol; 2014 Oct; 35(10):10457-65. PubMed ID: 25053594
    [TBL] [Abstract][Full Text] [Related]  

  • 6. SFRP2 methylation in fecal DNA--a marker for colorectal polyps.
    Oberwalder M; Zitt M; Wöntner C; Fiegl H; Goebel G; Zitt M; Köhle O; Mühlmann G; Ofner D; Margreiter R; Müller HM
    Int J Colorectal Dis; 2008 Jan; 23(1):15-9. PubMed ID: 17639423
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Detection of colorectal neoplasm using promoter methylation of ITGA4, SFRP2, and p16 in stool samples: a preliminary report in Korean patients.
    Chang E; Park DI; Kim YJ; Kim BK; Park JH; Kim HJ; Cho YK; Sohn CI; Jeon WK; Kim BI; Kim HD; Kim DH; Kim YH
    Hepatogastroenterology; 2010; 57(101):720-7. PubMed ID: 21033217
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sensitive and Noninvasive Detection of Aberrant SFRP2 and MGMT-B Methylation in Iranian Patients with Colon Polyps.
    Naini MA; Mokarram P; Kavousipour S; Zare N; Atapour A; Zarin1 MH; Mehrabani G; Borji M
    Asian Pac J Cancer Prev; 2016; 17(4):2185-93. PubMed ID: 27221916
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diagnostic and prognostic value of the methylation status of secreted frizzled-related protein 2 in colorectal cancer.
    Tang D; Liu J; Wang DR; Yu HF; Li YK; Zhang JQ
    Clin Invest Med; 2011 Apr; 34(2):E88-95. PubMed ID: 21463549
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The variation trends of SFRP2 methylation of tissue, feces, and blood detection in colorectal cancer development.
    Sui C; Ma J; Chen Q; Yang Y
    Eur J Cancer Prev; 2016 Jul; 25(4):288-98. PubMed ID: 26258809
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of combined detection of multigene mutation and SDC2/SFRP2 methylation in stool specimens for colorectal cancer early diagnosis.
    Lin J; Zhang L; Chen M; Chen J; Wu Y; Wang T; Lu Y; Ba Z; Cheng X; Xu R; Tian T; Sun A; Zhang T; Chen M
    Int J Colorectal Dis; 2022 Jun; 37(6):1231-1238. PubMed ID: 35499710
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hypermethylation of SFRP2 as a potential marker for stool-based detection of colorectal cancer and precancerous lesions.
    Huang Z; Li L; Wang J
    Dig Dis Sci; 2007 Sep; 52(9):2287-91. PubMed ID: 17410438
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of a prototype reverse hybridization assay and MethyLight for detection of SFRP2 promotor methylation in fecal DNA.
    Kriegshäuser G; Enko D; Zitt M; Oberwalder M; Oberkanins C; Öfner D; Zeillinger R; Maximilian Müller H
    Int J Biol Markers; 2017 Oct; 32(4):e467-e470. PubMed ID: 28777432
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Performance of a MethyLight assay for methylated SFRP2 DNA detection in colorectal cancer tissue and serum.
    Li H; Wang Z; Zhao G; Ma Y; Chen Y; Xue Q; Zheng M; Fei S
    Int J Biol Markers; 2019 Mar; 34(1):54-59. PubMed ID: 30852954
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Analysis of fecal DNA methylation to detect gastrointestinal neoplasia.
    Nagasaka T; Tanaka N; Cullings HM; Sun DS; Sasamoto H; Uchida T; Koi M; Nishida N; Naomoto Y; Boland CR; Matsubara N; Goel A
    J Natl Cancer Inst; 2009 Sep; 101(18):1244-58. PubMed ID: 19700653
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Quantitative detection of SRY-Box 21 (
    Moradi K; Babaei E; Hosseinpour Feizi MA; Safaralizadeh R; Rezvani N
    Indian J Cancer; 2021; 58(2):217-224. PubMed ID: 33402569
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A systematic review and quantitative assessment of methylation biomarkers in fecal DNA and colorectal cancer and its precursor, colorectal adenoma.
    Liu R; Su X; Long Y; Zhou D; Zhang X; Ye Z; Ma J; Tang T; Wang F; He C
    Mutat Res Rev Mutat Res; 2019; 779():45-57. PubMed ID: 31097151
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Analysis of promoter methylation in stool: a novel method for the detection of colorectal cancer.
    Lenhard K; Bommer GT; Asutay S; Schauer R; Brabletz T; Göke B; Lamerz R; Kolligs FT
    Clin Gastroenterol Hepatol; 2005 Feb; 3(2):142-9. PubMed ID: 15704048
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Aging related methylation influences the gene expression of key control genes in colorectal cancer and adenoma.
    Galamb O; Kalmár A; Barták BK; Patai ÁV; Leiszter K; Péterfia B; Wichmann B; Valcz G; Veres G; Tulassay Z; Molnár B
    World J Gastroenterol; 2016 Dec; 22(47):10325-10340. PubMed ID: 28058013
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of epigenetic silencing of the SFRP2 gene in colorectal cancer as a clinical biomarker and molecular significance.
    Boughanem H; Pilo J; García-Flores LA; Arranz I; Ramos-Fernandez M; Ortega-Castan M; Crujeiras AB; Sandoval J; Macias-Gonzalez M
    J Transl Med; 2024 May; 22(1):509. PubMed ID: 38802858
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.